A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them

Therapeutic Agents:
Development........................................ 41,216,000
Clinical Trials.................................. 36,337,000
Vaccines:
Development...................................... 20,432,000
2. Risk Assessment and Prevention.................................... $ 17,614,000
Surveillance:
Diseases associated with HIV........................ $ 3,260,000
Population-Based Research: Natural History, Transmission,
Risk Factors:
Transmission:
Sexual........................................... 1,427,000
Hemophilia population............................... 797,000
Perinatal infection................................ 2,674,000
Other/M isc........................................ 3,346,000
Natural history and cofactors........................... 6,110,000
TOTAL.............................................. $ 159,834,000
The NCI AIDS/HIV Coordinator is:
Dr. Judy Karp
NCI
Building 31, Room 4A46
9000 Rockville Pike
Bethesda, MD 20892
301/496-3505
National Center for Research Resources
The National Center for Research Resources (NCRR) provides an infrastructure for multidisciplinary
studies on children and adults by providing: patient research facilities; computerized data management and
analysis; laboratories designed to translate clinical research into medical practice; research nurses, dietitians, and biostatisticians.
NCRR FY 1991 HIV Funding

1. Basic Science Research.............................................. $
Biomedical Research
HIV and HIV genome................................. $ 5,691,000
Immunology........................................ 3,950,000
Blood/Blood products.................................. 90,000
Diagnostic methods/reagents development................. 811,000
Animal models and related studies....................... 3,501,000
Neuroscience and Neuropsychiatric Research................ 1,355,000
Behavioral Research:
Mechanisms of behavior and behavior change............. 1,082,000
Prevention of high-risk behaviors........................ 97,000
Therapeutic Agents:
Development......................................... 2,145,000
Clinical trials....................................... 17,394,000
Vaccines:
Development....................................... 7,094,000
Research Enhancement:
Construction (Extramural).............................. 201,000
2. Risk Assessment and Prevention....................................... $
Population-Based Research: Natural History, Transmission,
Risk Factors:

43,411,000

4,085,000

32

Reproduction By Permission Only

~1991 ASAP

32 Reproduction By Permission Only ~1991 ASAP